Cart
sales@molnova.com
SACLAC
CAS No. 2248703-42-4
SACLAC( —— )
Catalog No. M37347 CAS No. 2248703-42-4
SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | In Stock |
|
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 25MG | 994 | In Stock |
|
| 50MG | 1371 | In Stock |
|
| 100MG | 1773 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSACLAC
-
NoteResearch use only, not for human use.
-
Brief DescriptionSACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
DescriptionSACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | Caspase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2248703-42-4
-
Formula Weight377.99
-
Molecular FormulaC20H40ClNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H]([C@@H](CCCCCCCCCCCCCCC)O)(NC(CCl)=O)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
RAPTA-C
RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.
-
Polygalacin D
Polygalacin D shows anti- proliferation, anti-inflammary, and hepatoprotective activities.
-
GSK854
GSK854 is a highly selective and potent inhibitor of troponin I interacting kinase (TNNI3K) that inhibits myocardial infarction-injured cellular pyroptosis and apoptosis in mice, which may limit oxidative stress, injury, and adverse remodeling in the ischemic heart.
